≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Birth asphyxia

DOID EFO Endpoint Browser PheWeb

P16_BIRTH_ASPHYXIA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — P21
  • Cause of death: ICD-10 — P21

2 out of 7 registries used, show all original rules.

207

4. Check minimum number of events

None

207

5. Include endpoints

None

207

6. Filter based on genotype QC (FinnGen only)

187

Control definitions (FinnGen only)

Control exclude
P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P2
Name in latin
Asphyxia intra partum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 13251 5713 7536
Only index persons 7432 3138 4294
Unadjusted period prevalence (%)
Whole population 0.19 0.16 0.21
Only index persons 0.14 0.12 0.16
Median age at first event (years)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00

-FinnGen-

Key figures

All Female Male
Number of individuals 187 107 80
Unadjusted period prevalence (%) 0.04 0.04 0.04
Median age at first event (years) 0.00 0.00 0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
200
Matched controls
2000
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
+∞
138.0
116
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
21.5
84.7
73
52
P21.0
ICD-10 Finland
Severe birth asphyxia
+∞
80.8
72
*
P21.9
ICD-10 Finland
Birth asphyxia, unspecified
+∞
19.1
18
*
P24.0
ICD-10 Finland
Neonatal aspiration of meconium
+∞
14.8
14
*
P07.3
ICD-10 Finland
Other preterm infants
5.8
13.9
27
52
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
+∞
10.5
10
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
42.4
10.1
12
*
P02.1
ICD-10 Finland
Fetus and newborn affected by other forms of placental separation and haemorrhage
104.8
9.5
10
*
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
+∞
9.4
9
*
WX730
NOMESCO Finland
Conventional respirator
19.7
9.1
13
7
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
7.3
8.6
20
30
P91.02
ICD-10 Finland
Neonatal hypoxic-ischaemic encephalopathy, severe
+∞
8.4
8
*
WX930
NOMESCO Finland
Thepapeutic hypothermia
+∞
8.4
8
*
WX722
NOMESCO Finland
PEEP
11.5
7.9
14
13
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.9
7.5
23
64
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
83.0
7.5
8
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
7.3
7
*
P25.1
ICD-10 Finland
Pneumothorax originating in the perinatal period
+∞
7.3
7
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.7
7.1
24
72
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.2
6.6
18
46
M03BX01
ATC
baclofen; systemic
72.1
6.5
7
*
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
11.6
6.4
11
10
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
6.3
6
*
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
22
5.73
4.68
3.8
2.3
13.46
12.16
umol/l
0.43
12
22
7
9
8.01
3.59
1.0
1.0
—
—
—
0
0
6
6
10.25
3.52
1.0
1.3
—
—
—
0
0
8
15
5.51
3.22
1.0
1.1
—
—
—
0
0
59
387
1.74
3.03
3.7
2.7
2.40
2.40
mmol/l
0.06
54
361
6
9
6.83
2.89
4.2
2.3
22.37
24.88
umol/l
—
6
9
10
32
3.23
2.47
6.3
3.9
7.40
7.38
ph
—
10
32
38
235
1.76
2.36
3.9
3.3
13.02
14.10
umol/l
0.42
38
225
7
18
3.99
2.27
1.0
2.2
—
—
—
0
0
7
18
3.99
2.27
1.1
1.0
—
—
—
0
0
60
424
1.59
2.26
2.8
3.7
—
—
—
0
0
10
35
2.95
2.24
6.0
4.5
—
—
—
0
0
5
9
5.66
2.22
1.6
1.4
—
—
—
0
0
11
42
2.71
2.18
15.9
8.5
206.93
95.09
mg/mmol
0.31
11
36
36
225
1.73
2.16
2.4
2.3
15.42
14.05
ng/l
0.05
12
73
8
25
3.29
2.12
7.0
4.3
9.81
8.97
kpa
—
8
25
8
25
3.29
2.12
6.9
4.3
4.98
4.93
kpa
—
8
25
112
925
1.48
1.98
5.8
5.9
119.22
110.78
u/l
0.54
105
874
36
234
1.66
1.88
3.4
2.7
274.11
361.05
nmol/l
2.11
36
223
6
17
3.60
1.85
2.3
2.1
—
—
—
0
0
122
1033
1.46
1.85
9.3
10.1
2.35
2.27
e9/l
0.31
108
886
5
12
4.24
1.83
1.2
1.2
94.40
98.50
umol/l
—
5
12
16
288
0.52
1.78
2.6
1.7
—
—
—
0
0
7
25
2.86
1.66
2.7
3.0
16.79
17.58
%
—
7
25
28
177
1.68
1.62
3.4
6.3
73.73
67.74
e9/l
0.19
16
113
49
356
1.50
1.60
27.3
8.9
7.41
7.41
ph
0.05
41
286
91
745
1.41
1.57
5.3
3.5
0.00
0.00
estimate
-0.00
20
133
63
486
1.43
1.51
10.8
9.1
36.76
38.63
g/l
1.36
63
462
18
102
1.84
1.50
5.7
6.2
0.40
0.41
%
—
10
34
13
66
2.04
1.47
1.5
1.8
—
—
—
0
0
43
310
1.49
1.45
26.9
8.7
—
—
—
0
0
123
1075
1.37
1.37
10.7
11.8
3.24
3.49
e9/l
0.81
109
903
18
106
1.77
1.34
6.2
7.5
0.80
0.49
%
—
10
37
89
742
1.36
1.32
5.3
3.5
0.00
0.00
estimate
-0.00
19
133
47
354
1.43
1.27
4.8
3.4
0.00
0.00
estimate
-0.00
18
131
88
736
1.35
1.27
5.3
3.5
0.00
0.00
estimate
-0.00
20
137
50
382
1.41
1.25
7.6
5.1
—
—
—
0
0
118
1037
1.34
1.20
10.3
10.7
0.20
0.20
e9/l
0.16
104
886
7
30
2.38
1.13
1.4
1.6
—
—
—
0
0
115
1012
1.32
1.13
9.6
10.2
0.55
0.54
e9/l
0.07
98
846
42
317
1.41
1.12
5.0
3.8
7.38
7.38
ph
0.14
29
222
87
740
1.31
1.08
24.1
12.6
1.22
1.22
mmol/l
0.26
81
686
88
752
1.30
1.05
9.7
10.7
—
—
—
0
0
45
348
1.38
1.05
10.0
12.4
1.22
0.98
mmol/l
0.21
35
283
5
22
2.30
1.04
3.2
2.7
—
—
—
0
0
17
107
1.64
1.03
7.0
7.4
0.00
0.03
%
—
9
30
69
572
1.31
1.02
3.3
3.7
—
—
estimate
—
0
0
69
572
1.31
1.02
1.5
1.6
—
—
—
0
0
114
1011
1.30
1.02
9.7
10.2
0.03
0.04
e9/l
0.23
98
845
7
35
2.04
1.01
4.1
7.5
37.00
37.03
°c
—
7
35
30
219
1.44
0.97
2.7
2.6
9859.11
7269.30
u/l
—
9
62
24
168
1.49
0.95
9.7
17.2
103.92
105.19
mmol/l
0.36
24
168
17
111
1.58
0.91
4.9
3.5
—
—
—
0
0
16
103
1.60
0.90
6.8
7.5
0.00
0.03
%
—
8
33
21
145
1.50
0.89
4.6
4.5
83.50
101.06
mg/l
0.15
16
128
58
478
1.30
0.89
2.7
3.5
2.63
2.47
mg/l
0.30
53
428
11
64
1.76
0.88
2.1
1.6
—
—
—
0
0
44
351
1.33
0.85
10.4
12.4
7.36
7.36
ph
0.09
36
239
13
81
1.65
0.83
17.6
24.5
91.30
96.21
%
0.59
13
81
164
1546
1.34
0.82
10.4
9.4
26.04
24.08
u/l
0.28
159
1497
36
280
1.35
0.82
5.0
4.3
—
—
—
0
0
10
58
1.76
0.81
2.8
5.7
1083.50
370.98
mg/l
—
10
58
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
6
33
1.84
0.79
1.8
2.4
32.37
35.70
mmol/l
—
6
33
24
175
1.42
0.79
1.9
2.0
—
—
—
0
0
15
100
1.54
0.75
1.7
1.3
357.22
243.43
miu/ml
—
9
47
41
330
1.30
0.75
10.3
11.7
22.37
23.49
mmol/l
1.52
41
330
9
56
1.64
0.73
1.9
1.6
0.19
0.28
nmol/l
—
9
43
5
25
2.02
0.73
15.2
5.6
5.08
5.71
pmol/l
—
5
25
20
144
1.43
0.71
5.3
5.2
9.76
8.05
mg/mmol
0.13
15
126
7
41
1.73
0.70
2.4
2.6
71.43
92.53
mmol/l
—
7
32
40
328
1.27
0.64
15.7
14.8
—
—
—
0
0
38
310
1.28
0.63
7.1
4.1
1.63
2.38
e6/l
0.44
19
162
47
394
1.25
0.63
1.6
1.6
119.63
95.47
pmol/l
2.38
25
216
46
385
1.25
0.62
30.3
16.3
24.13
24.69
mmol/l
0.75
46
385
5
30
1.68
0.62
1.0
1.0
161.80
163.53
g/l
—
5
30
111
1018
1.20
0.61
2.7
2.3
5.25
5.31
mmol/l
0.42
105
932
12
80
1.53
0.61
18.6
24.8
0.66
0.68
%
0.08
12
80
43
359
1.25
0.60
4.9
4.5
1.10
1.09
inr
0.11
38
302
43
359
1.25
0.60
2.0
1.9
—
—
—
0
0
0
23
0.00
0.58
0.0
1.3
—
22.83
—
0
6
0
23
0.00
0.58
0.0
1.3
—
17.83
—
0
6
5
90
0.54
0.57
1.0
1.0
—
—
—
0
0
58
504
1.21
0.56
4.5
3.0
0.00
0.00
estimate
-0.00
16
112
6
38
1.60
0.55
1.7
7.0
—
—
—
0
0
6
38
1.60
0.55
2.2
2.0
—
—
—
0
0
9
61
1.50
0.54
2.3
4.5
22.44
16.87
%
—
9
61
45
382
1.23
0.54
4.7
2.8
0.00
0.00
estimate
-0.00
17
115
12
83
1.47
0.53
18.6
24.0
0.88
1.03
%
0.38
12
83
68
607
1.18
0.49
7.6
8.0
—
—
—
0
0
104
962
1.17
0.48
9.9
10.5
0.49
0.63
%
2.10
98
924
71
637
1.18
0.48
11.0
5.3
57.32
78.50
e6/l
0.25
47
415
16
120
1.36
0.48
1.1
1.4
—
—
—
0
0
104
966
1.16
0.45
9.9
10.5
2.96
3.06
%
0.17
99
923
26
315
0.80
0.45
1.5
1.8
—
—
—
0
0
13
95
1.39
0.45
2.6
1.7
6.14
6.39
ph
—
7
58
172
1664
1.24
0.44
16.7
11.7
18.72
23.15
mg/l
1.13
135
1176
20
250
0.78
0.44
1.5
1.8
—
—
—
0
0
17
216
0.77
0.43
1.4
2.2
—
—
—
0
0
104
969
1.15
0.42
9.9
10.5
8.64
8.46
%
0.30
99
928
8
58
1.39
0.42
1.6
1.9
—
—
—
0
0
8
58
1.39
0.42
1.6
1.9
—
—
—
0
0
8
58
1.39
0.42
1.6
1.9
—
—
—
0
0
8
58
1.39
0.42
1.0
1.2
—
—
—
0
0
8
58
1.39
0.42
1.6
1.9
—
—
—
0
0
18
141
1.30
0.42
1.6
2.8
24.15
32.45
u/l
0.81
13
110
11
79
1.42
0.41
2.5
1.7
16.75
20.02
ng/l
0.52
11
79
28
233
1.23
0.41
2.6
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.4
—
5351.83
—
0
12
5
34
1.48
0.40
1.0
2.2
15.40
3.71
u/ml
—
5
34
13
97
1.36
0.40
7.2
4.5
24.67
23.21
nmol/l
0.15
13
97
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
23
189
1.25
0.38
3.0
4.5
8.41
9.08
g/l
0.46
23
183
70
639
1.15
0.37
5.3
3.2
6.24
6.35
ph
0.37
39
296
25
297
0.82
0.37
1.4
1.8
—
—
—
0
0
9
71
1.28
0.36
1.0
1.0
—
—
—
0
0
27
317
0.83
0.36
1.4
1.8
—
—
—
0
0
6
43
1.41
0.35
2.2
1.2
—
1.88
—
0
5
27
316
0.83
0.35
1.4
1.8
—
—
—
0
0
103
969
1.13
0.34
11.4
12.0
0.00
0.00
e9/l
0.50
82
731
6
45
1.34
0.34
2.7
1.4
—
—
—
0
0
27
315
0.83
0.34
1.4
1.7
—
—
—
0
0
14
176
0.78
0.33
1.2
1.3
184.80
162.05
u/ml
—
5
57
6
46
1.31
0.33
2.7
1.3
—
—
—
0
0
53
479
1.14
0.32
8.9
4.4
0.11
0.23
e6/l
0.94
40
353
12
92
1.32
0.32
2.9
1.2
—
—
—
0
0
147
1417
1.14
0.32
4.4
4.2
1.98
1.97
mu/l
0.04
141
1347
22
184
1.22
0.32
2.4
3.3
2952.63
1116.33
ng/l
—
8
90
57
519
1.14
0.31
9.7
4.6
9.77
29.20
e6/l
2.24
44
393
7
97
0.71
0.31
3.9
2.1
—
—
—
0
0
7
54
1.31
0.30
2.0
4.2
24.86
26.76
%
—
7
54
7
55
1.28
0.30
3.4
6.1
—
—
—
0
0
7
56
1.26
0.29
2.1
4.2
62.00
67.54
%
—
7
56
7
56
1.26
0.29
2.0
4.2
8.29
8.30
%
—
7
56
11
85
1.31
0.28
20.8
23.4
22.65
23.77
mmol/l
0.83
11
85
8
66
1.22
0.27
1.0
1.3
—
—
—
0
0
13
160
0.80
0.27
5.6
1.8
—
—
—
0
0
13
105
1.25
0.25
1.1
1.1
—
—
—
0
0
29
256
1.16
0.25
5.1
5.3
1.74
2.27
mg/l
0.20
22
176
11
88
1.26
0.23
2.0
18.1
0.69
0.58
%
0.43
11
88
5
39
1.29
0.23
5.6
3.5
3.56
3.01
e9/l
—
5
39
7
92
0.75
0.23
1.1
1.1
—
—
—
0
0
17
144
1.20
0.23
2.4
2.5
14.86
7.88
iu/l
—
10
92
0
11
0.00
0.21
0.0
1.1
—
173.91
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
3.4
—
—
—
0
0
0
12
0.00
0.21
0.0
2.5
—
97.08
—
0
12
5
43
1.17
0.21
1.6
1.5
1.47
33.10
u/ml
—
5
32
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
46
425
1.11
0.20
2.1
2.0
1.37
1.19
mmol/l
0.67
46
401
6
48
1.26
0.20
1.0
1.0
1.35
1.51
g/l
—
6
48
6
48
1.26
0.20
1.0
1.0
0.87
0.79
g/l
—
6
48
9
115
0.77
0.20
1.1
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
4.4
—
4.88
—
0
14
23
203
1.15
0.20
1.6
8.0
4.37
6.94
umol/l
0.82
18
175
6
50
1.21
0.20
3.7
6.2
—
—
—
0
0
11
90
1.24
0.19
1.4
1.5
—
—
—
0
0
7
62
1.13
0.17
1.0
1.1
—
8.19
—
0
11
9
80
1.13
0.15
3.7
2.6
45.62
52.47
%
—
9
80
72
688
1.07
0.15
2.0
2.2
—
—
—
0
0
19
169
1.14
0.15
1.3
1.2
0.34
0.93
u/ml
0.75
12
119
76
728
1.07
0.15
1.6
1.8
1.77
1.58
g/l
0.49
41
392
19
170
1.13
0.14
1.3
1.2
16.13
7.66
u/ml
0.64
14
128
12
103
1.18
0.14
1.2
1.1
—
17.07
—
0
14
44
414
1.08
0.13
2.0
1.8
—
—
—
0
0
6
54
1.11
0.09
3.2
2.3
0.18
0.41
nmol/l
—
6
47
16
175
0.91
0.09
1.7
1.7
—
—
—
0
0
6
55
1.09
0.09
2.0
4.2
31.30
36.69
%
—
6
55
5
62
0.80
0.08
1.2
20.9
82.60
68.45
%
—
5
62
7
65
1.08
0.08
3.6
2.8
—
—
—
0
0
28
295
0.94
0.07
1.8
1.8
—
—
—
0
0
19
177
1.08
0.07
1.3
1.3
0.20
3.55
u/ml
3.42
13
127
162
1635
0.95
0.06
12.7
7.8
—
—
—
0
0
33
344
0.95
0.06
1.3
1.3
—
—
—
0
0
13
141
0.92
0.05
1.5
2.1
—
—
—
0
0
22
208
1.06
0.05
1.1
1.2
25.60
17.96
iu/ml
—
5
42
130
1285
1.03
0.05
3.9
3.6
14.58
14.46
pmol/l
0.26
124
1145
82
806
1.03
0.04
2.0
1.8
1.07
2.57
u/ml
0.88
15
156
22
211
1.05
0.03
1.9
2.3
—
—
—
0
0
41
400
1.03
0.03
4.6
2.8
1.02
1.02
kg/l
1.15
28
238
96
949
1.02
0.03
4.4
3.7
43.48
47.39
ug/l
0.31
91
914
17
178
0.95
0.02
1.8
2.1
—
—
—
0
0
14
133
1.06
0.01
1.8
1.3
—
—
—
0
0
30
307
0.97
0.01
1.7
1.6
—
—
—
0
0
59
597
0.98
0.01
2.6
2.4
—
—
—
0
0
39
396
0.98
0.00
2.2
2.1
—
—
—
0
0
185
1851
0.99
0.00
24.4
17.3
4.63
4.63
e12/l
0.02
176
1776
185
1849
1.01
0.00
24.5
17.4
271.57
269.64
e9/l
0.15
176
1777
12
117
1.03
0.00
1.3
1.5
—
—
—
0
0
39
387
1.01
0.00
3.6
2.5
—
—
—
0
0
16
155
1.04
0.00
2.2
2.4
7.17
6.10
u/l
—
7
103
19
192
0.99
0.00
1.1
1.2
3.66
4.53
u/ml
—
5
56
185
1852
0.99
0.00
24.5
17.4
6.90
6.77
e9/l
0.35
176
1774
7
70
1.00
0.00
1.1
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
42.40
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
2150.00
—
0
6
0
5
0.00
-0.00
0.0
4.2
—
0.42
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
52
0.96
-0.00
1.8
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.1
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
24.80
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
106.60
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
4.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.8
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.6
0.38
0.64
g/l
—
5
42
0
5
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
3.45
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint P16_BIRTH_ASPHYXIA and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
P16_BIRTH_ASPHYXIA 2.191 [1.71, 2.8] < 0.001
Birth year 0.99 [0.98, 1.0] 0.038

During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 6809 males with P16_BIRTH_ASPHYXIA died.

Mortality risk

Mortality risk for people of age

years, who have P16_BIRTH_ASPHYXIA.

N-year risk Females Males
1 No data 0.517%
5 No data 2.843%
10 No data 7.153%
15 No data 12.962%
20 No data 22.039%

Relationships between endpoints

↥

Index endpoint: P16_BIRTH_ASPHYXIA – Birth asphyxia

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data